![Cory Jubinville](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cory Jubinville
Corporate Officer/Principal bij
VERTEX PHARMACEUTICALS INCORPORATED
Profiel
Dr. Cory Jubinville is a Director-Corporate Strategy at Vertex Pharmaceuticals, Inc. and a Director-Corporate Strategy at Crinetics Pharmaceuticals, Inc. Dr. Jubinville was previously employed as an Analyst by LifeSci Capital LLC.
He received his undergraduate degree from the University of Connecticut and a doctorate degree from the University of Connecticut.
Actieve functies van Cory Jubinville
| Bedrijven | Functie | Begin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-09-2026 |
| CRINETICS PHARMACEUTICALS | Corporate Officer/Principal | 01-02-2026 |
Eerdere bekende functies van Cory Jubinville
| Bedrijven | Functie | Einde |
|---|---|---|
LifeSci Capital LLC
 LifeSci Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-01-2026 |
Opleiding van Cory Jubinville
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
